The National Comprehensive Cancer Network® (NCCN) and Pfizer Global Medical Grants are collaborating to offer a new grant opportunity seeking proposals for investigator-sponsored research with elranatamab.

Pfizer is providing up to $5 Million Dollars in research grants to support clinical research studies to further evaluate the effectiveness of elranatamab in the treatment of Multiple Myeloma. Pfizer will serve as the funding organization. Grants are available to all investigators from institutions within the United States.

LOI required. See full RFP (pdf)